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Abstract 
Background: Fever is a common clinical symptom in children attending hospital outpatient clinics in rural Tanzania, 
yet there is still a paucity of data on the burden of bloodstream bacterial infection among these patients.
Methods: The present study was conducted at Korogwe District Hospital in north-eastern Tanzania. Patients aged 
between 2 and 59 months with a history of fever or measured axillary temperature ≥37.5°C attending the outpatient 
clinic were screened for enrolment into the study. Blood culturing was performed using the BACTEC 9050® system. 
A biochemical analytical profile index and serological tests were used for identification and confirmation of bacterial 
isolates. In-vitro antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method. The 
identification of Plasmodium falciparum malaria was performed by microscopy with Giemsa stained blood films.
Results: A total of 808 blood cultures were collected between January and October 2013. Bacterial growth was 
observed in 62/808 (7.7%) of the cultured samples. Pathogenic bacteria were identified in 26/808 (3.2%) cultures and 
the remaining 36/62 (58.1%) were classified as contaminants. Salmonella typhi was the predominant bacterial isolate 
detected in 17/26 (65.4%) patients of which 16/17 (94.1%) were from patients above 12 months of age. Streptococ-
cus pneumoniae was the second leading bacterial isolate detected in 4/26 (15.4%) patients. A high proportion of S. 
typhi 11/17 (64.7%) was isolated during the rainy season. S. typhi isolates were susceptible to ciprofloxacin (n = 17/17, 
100%) and ceftriaxone (n = 13/17, 76.5%) but resistant to chloramphenicol (n = 15/17, 88.2%). P. falciparum malaria 
was identified in 69/808 (8.5%) patients, none of whom had bacterial infection.
Conclusion: Bloodstream bacterial infection was not found to be a common cause of fever in outpatient children; 
and S. typhi was the predominant isolate. This study highlights the need for rational use of antimicrobial prescription 
in febrile paediatric outpatients presenting at healthcare facilities in rural Tanzania.
Keywords: Bacterial infection, Salmonella typhi, Malaria, Children, Antimicrobial sensitivity, Korogwe, Tanzania
© 2015 Mahende et al.. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Bacterial bloodstream infections are known common 
causes of febrile illnesses especially among children liv-
ing in resource poor areas of sub-Saharan Africa [1]. 
The epidemiology of bacterial infections varies across 
the world depending on geographical environment, 
social-economical status and the underlying illnesses 
such as malaria and human immunodeficiency virus 
(HIV) [2–4]. Invasive bacterial infections among hospi-
talized children have been extensively studied yet limited 
data exist on the disease burden among outpatient chil-
dren living in rural settings of Tanzania [5].
Bacterial infections among inpatient children in many 
parts of sub-Saharan Africa have been documented to 
be caused mainly by non-typhoidal Salmonella, Strep-
tococcus pneumoniae, Haemophilus influenzae and 
Escherichia coli [1, 6, 7]. Current data indicate differing 
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and changing pattern of bacterial infections in areas 
with declining malaria and HIV transmissions [3, 8–11]. 
Therefore, understanding the local epidemiology of path-
ogens is essential for early disease interventions.
The general clinical symptoms observed in patients 
with invasive bacterial infections include fever, head-
ache, abdominal pain, vomiting, diarrhoea and malaise 
[12]. Like other febrile illnesses, these signs and symp-
toms are non-specific and may overlap with other febrile 
infections making diagnosis in children difficult and chal-
lenging in the absence of appropriate laboratory confir-
mation [13, 14]. The majority of healthcare facilities with 
the exception of a few research laboratories in rural Afri-
can countries, lack adequate microbiologic blood culture 
facilities; which is the universally preferred and effective 
standard method for detection of bacterial pathogens 
[15]. As a result, clinicians incorrectly diagnose and treat 
patients based on clinical symptoms rather than labora-
tory evidence. Consequently, patients are often given the 
wrong diagnosis, which leads to inappropriate treatment, 
poor prognosis and promotion of antimicrobial drug 
resistance [16, 17].
Empirical fever treatment with antimicrobials such as 
amoxicillin and chloramphenicol obtained over the coun-
ter without prescription is common in Tanzania, and this 
accentuates the problem of antimicrobial resistance [18]. 
Multiple drug resistance among Gram negative bacterial 
isolates has been spreading and increasing globally over 
the years [19–21]. The antimicrobial susceptibility pat-
terns vary with geographical location, therefore, periodic 
surveillance of local patterns is crucial in monitoring this 
problem as well as for correct prescriptions and future 
targets for treatments.
A majority of studies have documented bacterial 
infections among hospitalised patients who are usually 
severely ill and already exposed to antimicrobial drugs 
before seeking professional medical care [22]. In Tan-
zania, data on the burden of bacterial infection among 
children attending outpatient clinics in rural hospitals is 
lacking. With the current observations on changing pat-
terns of bacterial infections, local prevalence and anti-
microbial resistance profile need to be characterised for 
timely interventions. The objective of the study was to 
identify bloodstream bacterial infections causing fever 
in young children attending outpatient clinic at Korogwe 
District Hospital in north-eastern Tanzania. The study 
characterised the in  vitro antimicrobial susceptibil-
ity pattern of bacterial isolates and provided an outline 




The study was conducted at Korogwe District Hospital 
(KDH) in Korogwe District north-eastern Tanzania (Fig-
ure  1). Approximately 73,275 children under the age of 
Figure 1 A map showing study area.
Page 3 of 8Mahende et al. BMC Res Notes  (2015) 8:289 
5 years live in Korogwe District [23]. The District expe-
riences temperatures between 18 and 20°C during the 
rainy season and 26–30°C during the dry season. The 
annual rainfall ranges from 700 to 1,000  mm with long 
rainy seasons extending from March to May and short 
rains in September and October. The majority of inhabit-
ants (80%) reside in rural settings, practicing subsistence 
farming and informal trade. The hospital receives around 
6,000 (2012 estimates) outpatient visits from under fives 
annually. The Korogwe District is an area with declining 
malaria transmission with a prevalence of around 13% 
according to surveys conducted from 2003 to 2008 [24]. 
Pneumococcal and rotavirus vaccines were introduced 
in Tanzania as part of the Expanded Program on Immu-
nization (EPI) in January 2013. The administrative cov-
erage for other vaccines in the EPI has been above 90% 
(Korogwe Primary Health Care report, District Medi-
cal Officer, personal communication). These vaccines 
include; Bacille Calmette–Guérin, pentavalent vaccine 
(diphtheria–tetanus–pertussis, hepatitis B and haemo-
philus influenza type B), poliovirus and measles vaccines.
Study participants
The study was conducted from January 2013 to October 
2013 where febrile children presenting at KDH outpa-
tient clinic were assessed for enrolment. The inclusion 
criteria were: children aged between 2 and 59  months 
presenting at KDH with a history of fever in the last 48 h 
or measured axillary temperature of ≥37.5°C at presen-
tation. Exclusion criteria included previous consultation 
for the presenting complaints, intake of antimalarial and/
or antibiotic drugs within the last 7 days, planned admis-
sions (e.g. elective surgery) and trauma/injury.
Ethics statement
The study was granted ethical clearance with reference 
number NIMR/HQ/R.8a/Vol.1X/1373 from the Tanza-
nian Medical Research Coordinating Committee. Par-
ent/legally accepted guardian of every child enrolled in 
the study provided a written informed consent by either 
signature or thumb print for the illiterate parent/legally 
accepted guardian.
Study procedures
A detailed medical history and a thorough clinical exami-
nation were performed on each patient and information 
was entered into a standardised case record form. This 
included demographic information, clinical history, physi-
cal examination data, vital signs (axillary temperature 
and respiratory rate) and body weight. Clinical diagno-
sis was made based on presenting signs and symptoms 
according to Integrated Management of Childhood Illness 
(IMCI) guidelines [25] so that patients could be managed 
appropriately according to the national standard practice 
[26, 27] while waiting for blood culture results.
Blood sampling and laboratory investigations
A maximum of 5  ml of venous blood was collected for 
laboratory investigations using aseptic techniques. Blood 
was drawn after disinfecting the venipuncture site with 
70% isopropyl alcohol and iodine. A blood volume of 
between 1 and 3 ml was inoculated into commercial BD 
BACTEC PEDS PLUS® culture bottles. A single aerobic 
culture bottle was used per patient. The inoculated blood 
culture bottles were immediately (that was within 2  h) 
incubated at 35°C in the BACTEC 9050® (Becton–Dickin-
son, Sparks, MD, USA) culture system for a maximum of 
5 days unless flagged positive. Sheep-blood, MacConkey 
and chocolate agar plates with the use of routine micro-
biological techniques were used for sub-culturing posi-
tive samples according to standard methods. Analytical 
Profile Index (API) biochemical test kit (BioMérieux®™, 
France) was used to identify pathogens. Salmonella iso-
lates were confirmed by serological tests using specific 
antisera (Becton–Dickinson, Sparks, MD, USA).
In-vitro antimicrobial susceptibility testing for patho-
genic bacterial isolates was performed using the Kirby-
Bauer disc diffusion method. The antimicrobial agents 
tested included; amoxicillin (10 µg), cefoxitin (30 µg), cef-
triaxone (30 µg), chloramphenicol (30 µg), ciprofloxacin 
(5  µg), clarithromycin (2  µg), co-trimoxazole (1.25  µg), 
gentamicin (10  µg), penicillin (1  µg) and tetracycline 
(30  µg). Clinical and Laboratory Standards Institute 
(CLSI) criteria were used in the interpretation of zone 
sizes [28].
The identification of malaria infection was performed 
by microscopy. Thick and thin blood smears were pre-
pared from venous blood collected in the ethylene 
diamine tetra acetic acid (EDTA) tubes. Blood slides 
were stained with a 5% Giemsa solution for 30 min and 
examined for asexual Plasmodium falciparum parasites. 
The parasite densities were calculated against 200 (500 
if parasite count was <10) leucocytes multiplied by the 
patient’s leucocyte count and expressed as parasites/μl. 
At least 100 high power microscopic fields of the thin 
film were examined to exclude the diagnosis of malaria. 
The slides were independently double-read by experi-
enced microscopists and in case of discrepancy, a third 
reading was performed. The complete blood count was 
analysed using the automated MS4s haematological ana-
lyser (Melet Schloesing Diamond Diagnostics, USA).
Quality control and assessment
Laboratory investigations were carried out at Korogwe 
Research Laboratory of the Tanzanian National Institute 
for Medical Research. Quality control was performed for 
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all laboratory methods according to standard guidelines 
[29]. During the study, the laboratory participated in the 
bacteriology external quality assessment programme 
with the National Institute for Communicable Diseases 
(NICD) registration number 107.
Case definitions
Fever was defined as history of abnormally high body 
temperature reported by the parent/guardian or meas-
ured axillary temperature ≥37.5°C on presentation. 
Bloodstream bacterial infection (bacteraemia) was 
defined as fever with isolation of pathogenic bacteria 
from a positive blood culture. A contaminant was defined 
as non-pathogenic bacteria (mostly from skin) such as 
coagulase-negative Staphylococcus species, Corynebac-
terium species, alpha- or gamma-hemolytic streptococci, 
Micrococcus species, Bacillus species and Propionibac-
terium species. However, a definitive diagnosis of a con-
taminant was decided by a clinician based on the clinical 
presentation of the patient considering that these organ-
isms could be the cause of an opportunistic infection. The 
monthly cut-off point for contamination rate during the 
study was 6%. Malaria infection was defined as fever with 
the presence of asexual P. falciparum parasites in a blood 
smear confirmed by microscopy. Clinical diagnoses were 
defined according to the IMCI guidelines [25]. Anae-
mia was defined as haemoglobin concentration below 
9.3 g/dL. The reference interval used was 4.5–17 × 103/µL 
for leucocyte count.
Data management and statistical analysis
Data management involved double entry and validation 
using Microsoft Access 2007. Data analysis was done 
by STATA version 11.2 (Stata Corp LP, College Sta-
tion, TX, USA). Variables were summarized as frequen-
cies and percentages, medians and inter-quartile ranges 
as appropriate. Categorical data were compared by the 
Chi-square test. The logistic regression (odds ratio and 
95% confidence interval) was used to determine associa-
tion of clinical diagnosis at enrolment with the occur-
rence of bacteraemia. The P value <0.05 was considered 
significant.
Results
During the study period of January 2013 to October 2013, 
a total of 1,380 patients were screened for enrolment. 
Five hundred and thirteen patients (37.2%) did not meet 
the inclusion criteria; 51/513 (9.9%) patients were not 
within the required age group, 153/513 (29.8%) patients 
were afebrile, 219/513 (42.7%) patients had used antima-
laria/antimicrobial drug within 7 days prior to screening 
and 90/513 (17.5%) patients refused participation. The 
remaining 867/1,380 (62.8%) patients were recruited of 
whom 808 had blood culture samples collected.
The median age of patients was 15.6  months (Inter-
quartile range: 8.9–30.0). The sex ratio was 431/808 
(53.3%) boys and 377/808 (46.7%) girls. The demographic 
profile of patients is indicated in Table 1.
Bacterial growth was observed in 62/808 (7.7%) of the 
cultured samples. Single pathogenic bacteria were iso-
lated from 26/808 (3.2%) cultures. The remaining 36/62 
(58.1%) were classified as contaminants. Coagulase-neg-
ative staphylococcus was the most frequently isolated 
contaminant with 21/36 (58.3%) of the bacterial isolates 
followed by micrococcus 9/36 (25%), Corynebacterium 
species 3/36 (8.3%), lactobacillus 1/36 (2.8%), Sphingo-
monas paucimobilis 1/36 (2.8%) and Citrobacter braakii 
1/36 (2.8%). Blood cultures that flagged positive from the 
BACTEC 9050® culture system with no bacteria growth 
accounted for 8/808 (0.9%) of the positive cultures.
Gram negative bacteria were the leading pathogenic 
bacterial isolates compared to the Gram positive bac-
teria. Salmonella typhi was the most prevalent bacte-
rial isolate identified in 17/26 (65.4%) cultures followed 
by S. pneumoniae at 4/26 (15.4%) and others as shown 
in Table 2. Pathogenic bacteria (n = 20/26, 76.9%) were 
commonly isolated from patients below 36  months 
of age. The majority of S. typhi 16/17 (94.1%) were iso-
lated from patients above 12 months of age whilst non-
typhoidal Salmonella 2/2 (100%) were from patients 
below 12 months of age (Table 2). A high proportion of 
S. typhi, 11/17 (64.7%), was isolated during the rainy sea-
son (March to May and September to October). Blood-
stream bacterial infection was not associated with gender 
(χ2 = 0.2, P = 0.65).
Clinical diagnosis and laboratory findings at enrol-
ment of patients with bacteraemia were compared with 
those without bacteraemia (Table  1). The proportion of 
bacteraemic patients with measured axillary temperature 
of ≥39°C was not of statistical significance (χ2  =  2.85, 
P = 0.09) when compared to the non-bacteraemic group. 
Out of 159/808 (19.7%) patients with clinical diagnosis 
of gastroenteritis, 8/159 (5%) patients had positive blood 
cultures and among them, six were S. typhi isolates. One 
S. pneumoniae isolate was identified from a patient with 
a clinical diagnosis of pneumonia. P. falciparum malaria 
was identified in 69/808 (8.5%) patients, none of whom 
had bacterial infection. Patients with the clinical diag-
nosis of non-specific febrile illness were at higher risk of 
having bacteraemia (OR = 7.6, 95% CI 3.3–17.4), P value 
<0.01). Eight S. typhi and two S. pneumoniae isolates 
were identified from these patients.
In-vitro antimicrobial susceptibility testing to selected 
antimicrobial agents was assessed for all pathogenic 
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bacterial isolates. S. typhi isolates were susceptible to cip-
rofloxacin 17/17(100%) and resistant to chloramphenicol 
15/17 (88.2%). A susceptibility rate of 100% was observed 
for S. pneumoniae isolates to chloramphenicol. All bacte-
rial isolates were observed to have high rates of resistance 
to amoxicillin and co-trimoxazole (Table 3).
Discussion
In the current study, bloodstream bacterial infection was 
not found to be a common cause of fever in outpatient 
children from rural Tanzania. Three previous studies 
which investigated bacterial infection similar to the pre-
sent study also showed a low prevalence of bacteraemia 
in the range of 1 and 5% [5, 30, 31]. A recent published 
finding of D’Acremont et  al., indicated evidence of a 
viral origin (70%) to be more common than evidence of 
a bacterial or parasitic origin in outpatient febrile chil-
dren from Tanzania [5]. When the distribution of patho-
genic bacteria was characterized according to age group, 
patients below 36 months of age had a higher prevalence 
of bacterial infection. A significant number of studies on 
Table 1 Demographic characteristics and clinical diagnosis of patients with bacteraemia
Data are n (%), IQR inter-quartile range.
a Conjunctivitis, fungal infection, gingivitis, hookworm infection, otitis media, skin infection, urinary tract infection.
Bacteraemia positive (n = 26) Bacteraemia negative (n = 782) P value
Girls 11 (42.3) 366 (46.8) 0.65
Age
 2–35 months 20 (76.9) 654 (83.6) 0.40
 36–59 months 6 (23.1) 128 (16.4)
 Axillary temperature (°C), median (IQR) 38.3 (37.6–39.3) 38 (37.5–38.7)
 Axillary temperature ≥39°C 7 (26.9) 116 (14.8) 0.09
Symptoms
 Cough 5 (19.2) 360 (46.0) 0.01
 Shortness of breath 2 (7.7) 87 (11.1) 0.58
 Diarrhoea 6 (23.1) 155 (19.8) 0.68
Clinical diagnosis at enrolment
 Malaria 0 (0) 69 (8.8) 0.11
 Gastroenteritis 8 (30.8) 151 (19.3) 0.15
 Upper respiratory tract infection 3 (11.5) 309 (39.5) <0.01
 Pneumonia 2 (7.7) 114 (14.6) 0.33
 Other infectionsa 1 (3.8) 59 (7.5) 0.17
 Multiple infectionsa 3 (11.5) 140 (17.9) 0.40
 Non-specific febrile illness 12 (46.2) 80 (10.2) <0.01
Laboratory findings (n = 785)
 Anaemia 6/26 (23.1) 203/759 (26.7) 0.68
 Leucocyte count (103/µL), median (IQR) 10.4 (7.5–16.3) 11.5 (8.6–15.7)
 Leucocyte count >17 (103/µL) 6/26 (23.1) 157/759 (20.7) 0.77

















0 (0) 1 (6.7) 0 (0) 1 (3.8)
 Streptococcus 
pneumoniae




0 (0) 1 (6.7) 0 (0) 1 (3.8)
 Escherichia coli 1 (20) 0 (0) 0 (0) 1 (3.8)
 Non-typhoidal 
Salmonella
2 (40) 0 (0) 0 (0) 2 (7.7)
 Salmonella typhi 1 (20) 10 (66.7) 6 (100) 17 (65.4)
Total bacterial 
isolates
5 15 6 26
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bacteraemia in African children have reported higher 
prevalence of bacterial isolates from children below 
36 months of age similar to what is reported in this paper 
[20, 32]. Young children are usually susceptible to infec-
tions because of their immature immune system [33]. 
This study did not find any association between gender 
and bacterial infection in contrast to what was reported 
by Were and colleagues on the study among Kenyan chil-
dren [13].
The Gram negative bacteria were the leading isolates 
with S. typhi being the most predominant. This indicates 
the occurrence of typhoid fever among young pre-school 
children in this particular community, which was other-
wise thought to be uncommon within this age group [7]. 
Recent published work from sub-Saharan African coun-
tries with declining malaria transmissions has reported 
the predominance of S. typhi bacteria over other bacte-
rial isolates (especially the non-typhoidal Salmonella) 
[31, 34, 35]. The current findings from the study which 
was conducted in an area with low prevalence of malaria 
infection are in keeping with previous findings [11, 36]. 
The observed change in the epidemiological pattern 
of bacterial infections may have been due to the scal-
ing up of malaria interventions, better detection meth-
ods of malaria and the introduction of pneumococcal 
vaccination [37]. Continuous surveillance of bacterial 
infections is crucial for both current and future disease 
interventions.
Nearly two-thirds of S. typhi isolates were identified 
during the rainy season suggesting that the environmen-
tal risk factors are important to the occurrence of typhoid 
[38]. Similar associations have been found in Malawi and 
Sierra Leone where the frequency of Salmonella infec-
tions has been associated with the rainy season [39, 40]. 
Therefore, Tanzania and other low-income countries 
should take measures and work towards protecting water 
sources in rural areas for control against spreading of 
the bacteria. This can be attained through good sanita-
tion to safe water and public health education on per-
sonal and food hygiene. Simultaneously, researchers and 
pharmaceutical companies should expedite development 
of vaccine against typhoid for immunization in children. 
Currently, typhoid vaccine is available for adult travelers 
from developed countries [41, 42].
In those patients who had the clinical diagnosis of non-
specific febrile illness at enrolment, the use of clinical 
symptoms and IMCI guidelines missed nearly half of the 
patients with culture-confirmed enteric fever. Apart from 
being febrile, these patients did not have other clinical 
symptoms or an elevated leucocyte count. Such patients 
would return at a future date with severe conditions 
requiring inpatient hospital stay. The availability of blood 
culture facility in the study has highlighted the impor-
tance of confirming the diagnosis of febrile illnesses 
caused by bacterial infections in children seeking hospi-
tal care. However, this is a difficult challenge to imple-
ment in hospital facilities in resource poor areas. These 
findings emphasize the need to develop highly sensitive 
and affordable point of care rapid diagnostic tests for use 
in resource limited areas to provide prompt detection 
of bacterial infections and timely initiation of effective 
antimicrobial therapy. This iterates the need of improv-
ing and having adequate microbiology laboratories at 
secondary healthcare facilities for local surveillance of 
bacteria pathogens as well as antimicrobial susceptibility 
patterns.
Chloramphenicol was not effective during the in vitro 
antimicrobial susceptibility testing of S. typhi isolates. 
Despite previous reports on its poor performance, it 
has been the recommended first-line antimicrobial of 
choice to young patients suspected of enteric infec-
tions attending healthcare facilities in Tanzania [17, 
Table 3 In-vitro antimicrobial susceptibility pattern of   
bacterial isolates






Salmonella typhi (n = 17)
 Amoxicillin 2 (11.8) 0 (0) 15 (88.2)
 Ceftriaxone 13 (76.5) 3 (17.6) 1 (5.9)
 Chloramphenical 2 (11.8) 0 (0) 15 (88.2)
 Ciprofloxacin 17 (100) 0 (0) 0 (0)
 Gentamicin 8 (47.1) 5 (29.4) 4 (23.5)
 Co-trimoxazole 1 (5.9) 2 (11.8) 14 (82.4)
Streptococcus pneumoniae (n = 4)
 Amoxicillin 1 (25) 0 (0) 3 (75)
 Cefoxitin 2 (50) 1 (25) 1 (25)
 Ceftriaxone 3 (75) 1 (25) 0 (0)
 Chloramphenicol 4 (100) 0 (0) 0 (0)
 Clarithromycin 3 (75) 0 (0) 1 (25)
 Co-trimoxazole 0 (0) 0 (0) 4 (100)
 Penicillin 0 (0) 0 (0) 4 (100)
Other Enterobacteriaceae (n = 4)
 Amoxicillin 2 (50) 0 (0) 2 (50)
 Ceftriaxone 4 (100) 0 (0) 0 (0)
 Chloramphenicol 3 (75) 0 (0) 1 (25)
 Ciprofloxacin 4 (100) 0 (0) 0 (0)
 Gentamicin 1 (25) 1 (25) 2 (50)
 Co-trimoxazole 2 (50) 0 (0) 2 (50)
Staphylococcus aureus (n = 1)
 Cefoxitin 0 (0) 0 (0) 1 (100)
 Chloramphenicol 1 (100) 0 (0) 0 (0)
 Gentamicin 1 (100) 0 (0) 0 (0)
 Penicillin 0 (0) 0 (0) 1 (100)
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27]. Meanwhile, chloramphenicol was found to have 
100% effectiveness against the Gram positive bacte-
rial isolates. Ceftriaxone and ciprofloxacin were effec-
tive antimicrobials for Gram negative bacterial isolates. 
Ceftriaxone is available for children under 5  years of 
age, but usually expensive and often administered for 
inpatients where as ciprofloxacin is not recommended 
for use in young children due to its adverse effects [27, 
43]. This study found low susceptibility of S. pneu-
moniae isolates to amoxicillin despite this drug being 
commonly used for treating acute respiratory infec-
tions in Tanzanian children [27]. These data highlight 
the need to conduct further studies so as to facilitate 
policy makers to revise antimicrobial use guidelines 
accordingly. Periodic in  vitro susceptibility testing 
of antimicrobials is essential to provide guidance for 
appropriate and effective treatment against bacterial 
infections as well as understanding the local antimicro-
bial resistance patterns. Hence, adequate microbiology 
laboratory facilities are essential and highly needed.
The study had some potential limitations. First, there 
was no confirmation evidence of prior use of antimicro-
bial drugs among patients instead the study relied on 
information provided by the parents/legal guardians. 
Second, the sensitivity of blood culture is known to be 
less than 100%. Therefore the use of a single culture bot-
tle may have contributed to the low detection of bacteria 
pathogens [44]. Third, difficulty in venous sampling from 
young patients might have added to the low yield of bac-
terial pathogens. Lastly, the study could not provide suf-
ficient bacterial isolates for in-depth characterisation of 
antimicrobial susceptibility pattern.
Conclusion
In conclusion, bacteraemia was uncommon. This study 
highlights the need for rational use of antimicrobial pre-
scription in febrile paediatric outpatients presenting at 
healthcare facilities in rural Tanzania. Accurate diagno-
sis of bacterial infections in Tanzania remains a challenge 
because of non-specific symptoms and the lack of reliable 
diagnostic tools. Clinicians are therefore advised to with-
hold prescription of antibiotics to non-severe cases of 
febrile illnesses unless proven by laboratory results.
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